NCT01224418 A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate Status COMPLETED Phase PHASE4
NCT01224041 Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate Status COMPLETED Phase PHASE4
NCT01223911 A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01221636 Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept Status WITHDRAWN Phase PHASE1
NCT01219933 A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE) Status COMPLETED Phase PHASE4
NCT01217814 Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers Status TERMINATED Phase PHASE2
NCT01217086 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) Status COMPLETED Phase PHASE3
NCT01215942 An Open Label Study for Participants With Rheumatoid Arthritis Status TERMINATED Phase PHASE3
NCT01214733 A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01213017 The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE3
NCT01211834 Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01208506 First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Status COMPLETED Phase PHASE4
NCT01198509 Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) Status COMPLETED Phase NA
NCT01198002 A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate Status TERMINATED Phase PHASE3
NCT01197755 Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate and Have Had Inadequate Response to Single TNF-alpha Antagonist Status COMPLETED Phase PHASE3
NCT01197534 Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding. Status COMPLETED Phase PHASE3